PeterAMcSweeneyMD

Oncology • Denver, CO

Hematologic Oncology

Physician

Join to view full profile

Dr. McSweeney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. McSweeney's full profile

Already have an account?

Office
2065 Ash Street
Denver, CO 80207
Phone+1 303-916-3360
Is this information wrong?

Summary

I am a specialist in HSCT and CAR T cell therapy. I have extensive clinical and research experience in the field of hematological malignancies.

Education & Training

University of Otago School of MedicineClass of 1982

Certifications & Licensure

CO State Medical License 1999 - 2025
MT State Medical License 2005 - 2010
WA State Medical License 1994 - 2000
American Board of Internal Medicine Internal Medicine

Clinical Trials

Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia Start of enrollment: 1999 Nov 01
Completed
Phase 2
Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients Start of enrollment: 2004 Mar 01
Unknown status
Phase 2
Scleroderma: Cyclophosphamide or Transplantation Start of enrollment: 2005 Jun 01
Completed
Phase 2, Phase 3
Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor Start of enrollment: 2004 Mar 01
Unknown status
Phase 2
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation Start of enrollment: 2005 Nov 01
Unknown status
Phase 2
Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant Start of enrollment: 2007 Mar 01
Recruiting
Phase 2
SCOT Scleroderma Treatment Alternative Registry (STAR Registry) Start of enrollment: 2005 Jun 01
Completed
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant Start of enrollment: 2013 May 16
Completed
Phase 1
Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression Start of enrollment: 2010 Nov 01
Unknown status
Phase 3
Join now to see all

Publications & Presentations

PubMed

Myeloablation followed by hematopoietic stem cell transplantation leads to long-term normalization of systemic sclerosis molecular signatures.
Nancy Wareing, Xuan Wang, Lynette Keyes-Elstein, Marka A Lyons, Daniel E Furst, Leslie J Crofford, Beverly Welch, Ashley Pinckney, Maureen D Mayes, Keith M Sullivan, E...> ;Arthritis & Rheumatology. 2024 Mar 18
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids.
Olalekan O Oluwole, Edouard Forcade, Javier Muñoz, Sophie de Guibert, Julie M Vose, Nancy L Bartlett, Yi Lin, Abhinav Deol, Peter McSweeney, Andre H Goy, Marie José Ke...> ;Bone Marrow Transplantation. 2024 Mar 1
Remission of severe myasthenia gravis after autologous stem cell transplantation.
Monica I Schlatter, Soumya S Yandamuri, Kevin C O'Connor, Richard J Nowak, Minh C Pham, Abeer H Obaid, Callee Redman, Marie Provost, Peter A McSweeney, Michael L Pearl...> ;Annals of Clinical and Translational Neurology. 2023 Nov 1
47 citations
Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma.
Sattva S Neelapu, Caron A Jacobson, Armin Ghobadi, David B Miklos, Lazaros J Lekakis, Olalekan O Oluwole, Yi Lin, Ira Braunschweig, Brian T Hill, John M Timmerman, Abh...> ;Blood. 2023 May 11
4 citations
Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation.
Burcu Ayoglu, Michele Donato, Daniel E Furst, Leslie J Crofford, Ellen Goldmuntz, Lynette Keyes-Elstein, Judith James, Susan Macwana, Maureen D Mayes, Peter McSweeney,...> ;Annals of the Rheumatic Diseases. 2023 May 1
3 citations
Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis.
Julia Z Adamska, Amin Zia, Michelle S Bloom, Leslie J Crofford, Daniel E Furst, Ellen Goldmuntz, Lynette Keyes-Elstein, Maureen D Mayes, Peter McSweeney, Richard A Nas...> ;Annals of the Rheumatic Diseases. 2023 Mar 1
70 citations
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study.
Michael Wang, Javier Munoz, Andre Goy, Frederick L Locke, Caron A Jacobson, Brian T Hill, John M Timmerman, Houston Holmes, Samantha Jaglowski, Ian W Flinn, Peter A Mc...> ;Journal of Clinical Oncology. 2023 Jan 20
2 citations
Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.
Ankoor Shah, Jan Storek, Rob Woolson, Ashley Pinckney, Lynnette Keyes-Elstein, Paul K Wallace, Gregory D Sempowski, Peter McSweeney, Maureen D Mayes, Leslie Crofford, ...> ;Rheumatology. 2022 Oct 6
3 citations
Clinical and Molecular Findings after Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data.
Lynette Keyes-Elstein, Ashley Pinckney, Ellen Goldmuntz, Beverly Welch, Jennifer M. Franks, Viktor Martyanov, Tammara A. Wood, Leslie J. Crofford, Maureen D. Mayes, Pe...> ;Arthritis Care & Research. 2021 Sep 17
82 citations
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Olalekan O. Oluwole, Krimo Bouabdallah, Javier Munoz, Sophie de Guibert, Julie M. Vose, Nancy L. Bartlett, Yi Lin, Abhinav Deol, Peter A. McSweeney, Andre Goy, Marie J...> ;British Journal of Haematology. 2021 Jul 22
10 citations
Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis
Chiara Bellocchi, Jun Ying, Ellen Goldmuntz, Lynette Keyes-Elstein, John Varga, Monique Hinchcliff, Marka A. Lyons, Peter A. McSweeney, Daniel E. Furst, Richard A. Nas...> ;Arthritis & Rheumatology. 2021 Apr 1
19 citations
Machine learning predicts stem cell transplant response in severe scleroderma.
Jennifer M. Franks, Viktor Martyanov, Yue Wang, Tammara A. Wood, Ashley Pinckney, Leslie J. Crofford, Lynette Keyes-Elstein, Daniel E. Furst, Ellen Goldmuntz, Maureen ...> ;Annals of the Rheumatic Diseases. 2020 Sep 15
827 citations
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Michael Wang, Javier Munoz, Andre Goy, Frederick L. Locke, Caron A. Jacobson, Brian T. Hill, John M. Timmerman, Houston Holmes, Samantha Jaglowski, Ian W. Flinn, Peter...> ;The New England Journal of Medicine. 2020 Apr 1
10 citations
Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience.
Mazyar Shadman, David G. Maloney, Barry E. Storer, Brenda M. Sandmaier, Thomas R. Chauncey, Niels Smedegaard Andersen, Dietger Niederwieser, Judith A. Shizuru, Benedet...> ;Bone Marrow Transplantation. 2020 Jan 1
39 citations
Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures.
Shervin Assassi, Xuan Wang, Guocai Chen, Ellen Goldmuntz, Lynette Keyes-Elstein, Jun Ying, Paul K. Wallace, Jacob Turner, W. Jim Zheng, Virginia Pascual, John Varga, M...> ;Annals of the Rheumatic Diseases. 2019 Oct 1
19 citations
A randomized control trial of stress management for caregivers of stem cell transplant patients: Effect on patient quality of life and caregiver distress.
Mark L. Laudenslager, Teresa L. Simoneau, Susan K. Mikulich-Gilbertson, Crystal Natvig, Benjamin Brewer, Timothy S. Sannes, Kristin Kilbourn, Jon Gutman, Peter McSweeney> ;Psycho-Oncology. 2019 Aug 1
21 citations
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma.
Enrico Maffini, Barry E. Storer, Brenda M. Sandmaier, Benedetto Bruno, Firoozeh Sahebi, Judith A. Shizuru, Thomas R. Chauncey, Parameswaran Hari, Thoralf Lange, Michae...> ;Haematologica. 2019 Feb 1
1181 citations
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
Frederick L. Locke, Armin Ghobadi, Caron A. Jacobson, David B. Miklos, Lazaros J. Lekakis, Olalekan O. Oluwole, Yi Lin, Ira Braunschweig, Brian T. Hill, John M. Timmer...> ;The Lancet. Oncology. 2019 Jan 1
317 citations
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
Keith M. Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, Peter A. McSweeney, Ashley Pinckney, Beverly Welch, Maureen D. Mayes, Richard A. Nash, Leslie J. Crofford, B...> ;The New England Journal of Medicine. 2018 Jan 3
3136 citations
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, David B. Miklos, Caron A. Jacobson, Ira Braunschweig, Olalekan O. Oluwole, Tanya Siddiqi,...> ;The New England Journal of Medicine. 2017 Dec 10
360 citations
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
Matthew S. Davids, Haesook T. Kim, Pavan Bachireddy, Caitlin Costello, Rebecca Liguori, Alexandra Savell, Alexander Lukez, David Avigan, Yi-Bin Chen, Peter McSweeney, ...> ;The New England Journal of Medicine. 2016 Jul 13
60 citations
A randomized control trial of a psychosocial intervention for caregivers of allogeneic hematopoietic stem cell transplant patients: effects on distress.
Mark L. Laudenslager, Teri L. Simoneau, Kristin Kilbourn, Crystal Natvig, Sam Philips, Janet Spradley, Patrick Benitez, Peter McSweeney, Susan K. Mikulich-Gilbertson> ;Bone Marrow Transplantation. 2015 May 11
50 citations
Elevated peri‐transplant distress in caregivers of allogeneic blood or marrow transplant patients
Teresa L. Simoneau, Susan K. Mikulich-Gilbertson, Crystal Natvig, Kristin Kilbourn, Janet Spradley, Rachel Grzywa-Cobb, Samuel Philips, Peter McSweeney, Mark L. Lauden...> ;Psycho-Oncology. 2013 Sep 1
29 citations
Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program.
Paul J. Shaughnessy, Joseph P. Uberti, Steve Devine, Richard T. Maziarz, Julie M. Vose, Ivana N. Micallef, Eric N. Jacobsen, John M. McCarty, Patrick J. Stiff, Andrew ...> ;Bone Marrow Transplantation. 2013 Jun 1
19 citations
Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin
Fabiana Ostronoff, Filippo Milano, Ted Gooley, Jonathan A. Gutman, Peter A. McSweeney, Finn Bo Petersen, Brenda M. Sandmaier, R Storb, Colleen Delaney> ;Bone Marrow Transplantation. 2013 Jun 1
Join now to see all

Journal Articles

Long Term Follow-up of Tandem Autologous-Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma
Parameswaran Hari, Brenda M Sandmaier, Pamela S Becker, Leona Holmberg, Damian J Green, Peter A McSweeney, David G Maloney, Thomas R Chauncey, Haematologica

Abstracts/Posters

KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results of the Phase...
Peter A. McSweeney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019